메뉴 건너뛰기




Volumn 62, Issue S1, 2015, Pages S15-S24

Hepatic fibrosis: Concept to treatment

Author keywords

Antifibrotic; Fibrosis; Hepatic stellate cells; Liver

Indexed keywords

ANTIFIBROTIC AGENT; BIOLOGICAL MARKER; LYSYL OXIDASE 2; PROTEIN LYSINE 6 OXIDASE; UNCLASSIFIED DRUG;

EID: 84930654452     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.02.039     Document Type: Review
Times cited : (565)

References (80)
  • 2
    • 84928898387 scopus 로고    scopus 로고
    • Pathobiology of liver fibrosis: A translational success story
    • gutjnl-2014-306842 [Epub ahead of print]
    • Y.A. Lee, M.C. Wallace, and S.L. Friedman Pathobiology of liver fibrosis: a translational success story Gut 2015 http://dx.doi.org/10.1136/gutjnl-2014-306842, pii: gutjnl-2014-306842 [Epub ahead of print]
    • (2015) Gut
    • Lee, Y.A.1    Wallace, M.C.2    Friedman, S.L.3
  • 4
    • 33847350691 scopus 로고    scopus 로고
    • Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
    • T.A. Wynn Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases J Clin Invest 117 2007 524 529
    • (2007) J Clin Invest , vol.117 , pp. 524-529
    • Wynn, T.A.1
  • 5
    • 0019230284 scopus 로고
    • Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and Vitamin A-storing cells in extrahepatic organs
    • K. Wake Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and vitamin A-storing cells in extrahepatic organs Int Rev Cytol 66 1980 303 353
    • (1980) Int Rev Cytol , vol.66 , pp. 303-353
    • Wake, K.1
  • 7
    • 84896754721 scopus 로고    scopus 로고
    • Transcriptional repression of the transforming growth factor β (TGF-β) Pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by Nuclear Factor κb (NF-κB) p50 enhances TGF-β signaling in hepatic stellate cells
    • C. Liu, X. Chen, L. Yang, T. Kisseleva, D.A. Brenner, and E. Seki Transcriptional repression of the transforming growth factor β (TGF-β) Pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by Nuclear Factor κB (NF-κB) p50 enhances TGF-β signaling in hepatic stellate cells J Biol Chem 289 2014 7082 7091
    • (2014) J Biol Chem , vol.289 , pp. 7082-7091
    • Liu, C.1    Chen, X.2    Yang, L.3    Kisseleva, T.4    Brenner, D.A.5    Seki, E.6
  • 8
    • 69949160564 scopus 로고    scopus 로고
    • Redox mechanisms in hepatic chronic wound healing and fibrogenesis
    • E. Novo, and M. Parola Redox mechanisms in hepatic chronic wound healing and fibrogenesis Fibrogenesis Tissue Repair 1 2008 5
    • (2008) Fibrogenesis Tissue Repair , vol.1 , pp. 5
    • Novo, E.1    Parola, M.2
  • 9
    • 40849083460 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver: The mist gradually clear
    • N.M.W. De Alwis, and C.P. Day Non-alcoholic fatty liver: the mist gradually clear J Hepatol 48 2008 S105 S112
    • (2008) J Hepatol , vol.48 , pp. S105-S112
    • De Alwis, N.M.W.1    Day, C.P.2
  • 10
    • 84896806249 scopus 로고    scopus 로고
    • Liver fibrosis and repair: Immune regulation of wound healing in a solid organ
    • A. Pellicoro, P. Ramachandran, J.P. Iredale, and J.A. Fallowfield Liver fibrosis and repair: immune regulation of wound healing in a solid organ Nat Rev Immunol 14 2014 181 194
    • (2014) Nat Rev Immunol , vol.14 , pp. 181-194
    • Pellicoro, A.1    Ramachandran, P.2    Iredale, J.P.3    Fallowfield, J.A.4
  • 12
    • 84857055199 scopus 로고    scopus 로고
    • Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
    • C. Baeck, A. Wehr, K.R. Karlmark, F. Heymann, M. Vucur, N. Gassler, and et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury Gut 61 2012 416 426
    • (2012) Gut , vol.61 , pp. 416-426
    • Baeck, C.1    Wehr, A.2    Karlmark, K.R.3    Heymann, F.4    Vucur, M.5    Gassler, N.6
  • 13
    • 84906535982 scopus 로고    scopus 로고
    • Roles for chemokines in liver disease
    • F. Marra, and F. Tacke Roles for chemokines in liver disease Gastroenterology 147 2014 577 594
    • (2014) Gastroenterology , vol.147 , pp. 577-594
    • Marra, F.1    Tacke, F.2
  • 14
    • 84898789996 scopus 로고    scopus 로고
    • Macrophage heterogeneity in liver injury and fibrosis
    • F. Tacke, and H.W. Zimmermann Macrophage heterogeneity in liver injury and fibrosis J Hepatol 60 2014 1090 1096
    • (2014) J Hepatol , vol.60 , pp. 1090-1096
    • Tacke, F.1    Zimmermann, H.W.2
  • 15
  • 16
    • 84898824175 scopus 로고    scopus 로고
    • Interactions between the intestinal microbiome and liver diseases
    • B. Schnabl, and D.A. Brenner Interactions between the intestinal microbiome and liver diseases Gastroenterology 146 2014 1513 1524
    • (2014) Gastroenterology , vol.146 , pp. 1513-1524
    • Schnabl, B.1    Brenner, D.A.2
  • 17
    • 34447317835 scopus 로고    scopus 로고
    • Vascular endothelial growth factor and angiopoietin-1 as hypoxia-dependent autocrine and paracrine factors stimulating migration and chemotaxis of activated human hepatic stellate cells
    • E. Novo, S. Cannito, E. Zamara, L. Valfrè di Bonzo, A. Caligiuri, C. Cravanzola, and et al. Vascular endothelial growth factor and angiopoietin-1 as hypoxia-dependent autocrine and paracrine factors stimulating migration and chemotaxis of activated human hepatic stellate cells Am J Pathol 170 2007 1942 1953
    • (2007) Am J Pathol , vol.170 , pp. 1942-1953
    • Novo, E.1    Cannito, S.2    Zamara, E.3    Valfrè Di Bonzo, L.4    Caligiuri, A.5    Cravanzola, C.6
  • 19
    • 84904795250 scopus 로고    scopus 로고
    • Epigenetics in liver disease
    • D.A. Mann Epigenetics in liver disease Hepatology 60 2014 1418 1425
    • (2014) Hepatology , vol.60 , pp. 1418-1425
    • Mann, D.A.1
  • 21
    • 84862195154 scopus 로고    scopus 로고
    • Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
    • T. Kisseleva, M. Cong, Y. Paik, D. Scholten, C. Jiang, C. Benner, and et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis Proc Natl Acad Sci U S A 109 2012 9448 9453
    • (2012) Proc Natl Acad Sci U S A , vol.109 , pp. 9448-9453
    • Kisseleva, T.1    Cong, M.2    Paik, Y.3    Scholten, D.4    Jiang, C.5    Benner, C.6
  • 22
    • 0030175327 scopus 로고    scopus 로고
    • Pyridinoline collagen cross-links in patients with chronic viral hepatitis and cirrhosis
    • A. Hayasaka, S. Ilda, N. Suzuki, F. Kondo, M. Miyazaki, and H. Yonemitsu Pyridinoline collagen cross-links in patients with chronic viral hepatitis and cirrhosis J Hepatol 24 1996 692 698
    • (1996) J Hepatol , vol.24 , pp. 692-698
    • Hayasaka, A.1    Ilda, S.2    Suzuki, N.3    Kondo, F.4    Miyazaki, M.5    Yonemitsu, H.6
  • 23
    • 2942622398 scopus 로고    scopus 로고
    • Spontaneous recovery from micronodular cirrhosis: Evidence for incomplete resolution associated with matrix cross-linking
    • R. Issa, X. Zhou, C.M. Constandinou, J. Fallowfield, H. Millward-Sadler, M.D. Gaca, and et al. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking Gastroenterology 126 2004 1795 1808
    • (2004) Gastroenterology , vol.126 , pp. 1795-1808
    • Issa, R.1    Zhou, X.2    Constandinou, C.M.3    Fallowfield, J.4    Millward-Sadler, H.5    Gaca, M.D.6
  • 24
    • 33746120376 scopus 로고    scopus 로고
    • Overexpression of Bcl-2 by activated human hepatic stellate cells: Resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans
    • E. Novo, F. Marra, E. Zamara, L. Valfrè di Bonzo, L. Monitillo, S. Cannito, and et al. Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans Gut 55 2006 1174 1182
    • (2006) Gut , vol.55 , pp. 1174-1182
    • Novo, E.1    Marra, F.2    Zamara, E.3    Valfrè Di Bonzo, L.4    Monitillo, L.5    Cannito, S.6
  • 25
    • 77956425361 scopus 로고    scopus 로고
    • Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment
    • V. Barry-Hamilton, R. Spangler, D. Marshall, S. McCauley, H.M. Rodriguez, M. Oyasu, and et al. Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment Nat Med 16 2010 1009 1017
    • (2010) Nat Med , vol.16 , pp. 1009-1017
    • Barry-Hamilton, V.1    Spangler, R.2    Marshall, D.3    McCauley, S.4    Rodriguez, H.M.5    Oyasu, M.6
  • 26
    • 84856461322 scopus 로고    scopus 로고
    • Antifibrotic therapy: Lost in translation?
    • D. Schuppan, and M. Pinzani Antifibrotic therapy: lost in translation? J Hepatol 56 2012 S66 S74
    • (2012) J Hepatol , vol.56 , pp. S66-S74
    • Schuppan, D.1    Pinzani, M.2
  • 27
    • 84877141184 scopus 로고    scopus 로고
    • Evolving therapies for liver fibrosis
    • D. Schuppan, and Y.O. Kim Evolving therapies for liver fibrosis J Clin Invest 123 2013 1887 1901
    • (2013) J Clin Invest , vol.123 , pp. 1887-1901
    • Schuppan, D.1    Kim, Y.O.2
  • 28
    • 84947121337 scopus 로고    scopus 로고
    • Antifibrotic therapies: Moving towards clinical translation
    • Mehal WZ, Schuppan D. Antifibrotic therapies: Moving towards clinical translation. Semin Liver Dis 2015.
    • (2015) Semin Liver Dis
    • Mehal, W.Z.1    Schuppan, D.2
  • 29
    • 84873726484 scopus 로고    scopus 로고
    • Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: A 5-year open-label follow-up study
    • P. Marcellin, E. Gane, M. Buti, N. Afdhal, W. Sievert, I.M. Jacobson, and et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study Lancet 381 2013 468 475
    • (2013) Lancet , vol.381 , pp. 468-475
    • Marcellin, P.1    Gane, E.2    Buti, M.3    Afdhal, N.4    Sievert, W.5    Jacobson, I.M.6
  • 30
    • 84864367149 scopus 로고    scopus 로고
    • A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
    • R. D'Ambrosio, A. Aghemo, M.G. Rumi, G. Ronchi, M.F. Donato, V. Paradis, and et al. A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis Hepatology 56 2012 532 543
    • (2012) Hepatology , vol.56 , pp. 532-543
    • D'Ambrosio, R.1    Aghemo, A.2    Rumi, M.G.3    Ronchi, G.4    Donato, M.F.5    Paradis, V.6
  • 32
    • 84939941663 scopus 로고    scopus 로고
    • Toward an integrated pipeline for protein biomarker development
    • S1570-9639(14)00229-5 [Epub ahead of print]
    • A.P. Drabovich, E. Martínez-Morillo, and E.P. Diamandis Toward an integrated pipeline for protein biomarker development Biochim Biophys Acta 2014 http://dx.doi.org/10.1016/j.bbapap.2014.09.006, pii: S1570-9639(14)00229-5 [Epub ahead of print]
    • (2014) Biochim Biophys Acta
    • Drabovich, A.P.1    Martínez-Morillo, E.2    Diamandis, E.P.3
  • 33
    • 40049097359 scopus 로고    scopus 로고
    • Liver cirrhosis
    • D. Schuppan, and N.H. Afdhal Liver cirrhosis Lancet 371 2008 838 851
    • (2008) Lancet , vol.371 , pp. 838-851
    • Schuppan, D.1    Afdhal, N.H.2
  • 34
    • 70350077449 scopus 로고    scopus 로고
    • Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapies
    • Y. Popov, and D. Schuppan Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies Hepatology 50 2009 1294 1306
    • (2009) Hepatology , vol.50 , pp. 1294-1306
    • Popov, Y.1    Schuppan, D.2
  • 35
    • 84860299294 scopus 로고    scopus 로고
    • Noninvasive methods to assess liver disease in patients with hepatitis B or C
    • L. Castera Noninvasive methods to assess liver disease in patients with hepatitis B or C Gastroenterology 142 2012 1293 1302
    • (2012) Gastroenterology , vol.142 , pp. 1293-1302
    • Castera, L.1
  • 36
    • 84918578495 scopus 로고    scopus 로고
    • Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C
    • T.G. Simon, L.Y. King, H. Zheng, and R.T. Chung Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C J Hepatol 62 2015 18 23
    • (2015) J Hepatol , vol.62 , pp. 18-23
    • Simon, T.G.1    King, L.Y.2    Zheng, H.3    Chung, R.T.4
  • 37
    • 84913580343 scopus 로고    scopus 로고
    • Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice
    • S. Yoshida, N. Ikenaga, S.B. Liu, Z.W. Peng, J. Chung, D.Y. Sverdlov, and et al. Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice Gastroenterology 147 2014 1378 1392
    • (2014) Gastroenterology , vol.147 , pp. 1378-1392
    • Yoshida, S.1    Ikenaga, N.2    Liu, S.B.3    Peng, Z.W.4    Chung, J.5    Sverdlov, D.Y.6
  • 38
    • 34247619364 scopus 로고    scopus 로고
    • Gene expression profiles during hepatic stellate cell activation in culture and in vivo
    • S. De Minicis, E. Seki, H. Uchinami, J. Kluwe, Y. Zhang, D.A. Brenner, and et al. Gene expression profiles during hepatic stellate cell activation in culture and in vivo Gastroenterology 132 2007 1937 1946
    • (2007) Gastroenterology , vol.132 , pp. 1937-1946
    • De Minicis, S.1    Seki, E.2    Uchinami, H.3    Kluwe, J.4    Zhang, Y.5    Brenner, D.A.6
  • 39
    • 77956123956 scopus 로고    scopus 로고
    • Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture
    • P.M. Gilbert, K.L. Havenstrite, K.E. Magnusson, and et al. Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture Science 329 2010 1078 1081
    • (2010) Science , vol.329 , pp. 1078-1081
    • Gilbert, P.M.1    Havenstrite, K.L.2    Magnusson, K.E.3
  • 40
    • 67650710740 scopus 로고    scopus 로고
    • The elastic modulus of Matrigel™ as determined by atomic force microscopy
    • S.S. Soofi, J.A. Last, S.J. Liliensiek, and et al. The elastic modulus of Matrigel™ as determined by atomic force microscopy J Struct Biol 167 2009 216 219
    • (2009) J Struct Biol , vol.167 , pp. 216-219
    • Soofi, S.S.1    Last, J.A.2    Liliensiek, S.J.3
  • 41
    • 29144531874 scopus 로고    scopus 로고
    • Mechanobiology in the third dimension
    • J.A. Pedersen, and M.A. Swartz Mechanobiology in the third dimension Ann Biomed Eng 33 2005 1469 1490
    • (2005) Ann Biomed Eng , vol.33 , pp. 1469-1490
    • Pedersen, J.A.1    Swartz, M.A.2
  • 42
    • 84887035390 scopus 로고    scopus 로고
    • Fibroblasts and the ground they walk on
    • D.J. Tschumperlin Fibroblasts and the ground they walk on Physiology (Bethesda) 28 2013 380 390
    • (2013) Physiology (Bethesda) , vol.28 , pp. 380-390
    • Tschumperlin, D.J.1
  • 43
    • 84883559642 scopus 로고    scopus 로고
    • In the beginning there were soft collagen-cell gels: Towards better 3D connective tissue models?
    • R.A. Brown In the beginning there were soft collagen-cell gels: towards better 3D connective tissue models? Exp Cell Res 319 2013 2460 2469
    • (2013) Exp Cell Res , vol.319 , pp. 2460-2469
    • Brown, R.A.1
  • 44
    • 84883552306 scopus 로고    scopus 로고
    • Fibroblast morphogenesis on 3D collagen matrices: The balance between cell clustering and cell migration
    • B. da Rocha-Azevedo, and F. Grinnell Fibroblast morphogenesis on 3D collagen matrices: the balance between cell clustering and cell migration Exp Cell Res 319 2013 2440 2446
    • (2013) Exp Cell Res , vol.319 , pp. 2440-2446
    • Da Rocha-Azevedo, B.1    Grinnell, F.2
  • 45
    • 84947054592 scopus 로고    scopus 로고
    • Decellularized human Liver as a natural 3D scaffold for organ Engineering and 3D-disease modelling
    • [Abstract]
    • G. Mazza, K. Rombouts, A.R. Hall, L. Urbani, L. Longato, A.M. Holmes, and et al. Decellularized human Liver as a natural 3D scaffold for organ Engineering and 3D-disease modelling Hepatology 60 2014 59A [Abstract]
    • (2014) Hepatology , vol.60 , pp. 59A
    • Mazza, G.1    Rombouts, K.2    Hall, A.R.3    Urbani, L.4    Longato, L.5    Holmes, A.M.6
  • 46
    • 27744512904 scopus 로고    scopus 로고
    • Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes
    • Y. Popov, E. Patsenker, P. Fickert, M. Trauner, and D. Schuppan Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes J Hepatol 43 2005 1045 1054
    • (2005) J Hepatol , vol.43 , pp. 1045-1054
    • Popov, Y.1    Patsenker, E.2    Fickert, P.3    Trauner, M.4    Schuppan, D.5
  • 47
    • 79955450436 scopus 로고    scopus 로고
    • Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice
    • Y. Popov, D.Y. Sverdlov, A.K. Sharma, K.R. Bhaskar, S. Li, T.L. Freitag, and et al. Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice Gastroenterology 140 2011 1642 1652
    • (2011) Gastroenterology , vol.140 , pp. 1642-1652
    • Popov, Y.1    Sverdlov, D.Y.2    Sharma, A.K.3    Bhaskar, K.R.4    Li, S.5    Freitag, T.L.6
  • 48
    • 0038374866 scopus 로고    scopus 로고
    • Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis
    • E. Ueberham, R. Low, U. Ueberham, K. Schönig, H. Bujard, R. Gebhardt, and et al. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis Hepatology 37 2003 1067 1078
    • (2003) Hepatology , vol.37 , pp. 1067-1078
    • Ueberham, E.1    Low, R.2    Ueberham, U.3    Schönig, K.4    Bujard, H.5    Gebhardt, R.6
  • 51
    • 84877920627 scopus 로고    scopus 로고
    • Precision-cut liver slices: A tool to model the liver ex vivo
    • P. Olinga, and D. Schuppan Precision-cut liver slices: a tool to model the liver ex vivo J Hepatol 58 2013 1252 1253
    • (2013) J Hepatol , vol.58 , pp. 1252-1253
    • Olinga, P.1    Schuppan, D.2
  • 52
    • 1342303482 scopus 로고    scopus 로고
    • Of mice and not men: Differences between mouse and human immunology
    • J. Mestas, and C.C. Hughes Of mice and not men: differences between mouse and human immunology J Immunol 172 2004 2731 2738
    • (2004) J Immunol , vol.172 , pp. 2731-2738
    • Mestas, J.1    Hughes, C.C.2
  • 53
  • 54
    • 77956639159 scopus 로고    scopus 로고
    • Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B
    • T.T. Chang, Y.F. Liaw, S.S. Wu, E. Schiff, K.H. Han, C.L. Lai, and et al. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B Hepatology 52 2010 886 893
    • (2010) Hepatology , vol.52 , pp. 886-893
    • Chang, T.T.1    Liaw, Y.F.2    Wu, S.S.3    Schiff, E.4    Han, K.H.5    Lai, C.L.6
  • 56
    • 84927798150 scopus 로고    scopus 로고
    • Effects of bariatric surgery on severe liver injury in morbid obese patients with proven NASH: A prospective study
    • Abstract 213
    • G. Lassailly, R. Caiazzo, D. Buob, M. Pigeyre, H. Verkindt, V. Raverdy, and et al. Effects of bariatric surgery on severe liver injury in morbid obese patients with proven NASH: a prospective study Hepatology 60 2014 Abstract 213
    • (2014) Hepatology , vol.60
    • Lassailly, G.1    Caiazzo, R.2    Buob, D.3    Pigeyre, M.4    Verkindt, H.5    Raverdy, V.6
  • 57
    • 20344397684 scopus 로고    scopus 로고
    • Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B
    • P. Liu, Y.Y. Hu, C. Liu, and et al. Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B World J Gastroenterol 11 2005 2892 2899
    • (2005) World J Gastroenterol , vol.11 , pp. 2892-2899
    • Liu, P.1    Hu, Y.Y.2    Liu, C.3
  • 58
    • 0028294206 scopus 로고
    • Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. The
    • R.E. Poupon, R. Poupon, and B. Balkau Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. The N Engl J Med 330 1994 1342 1347
    • (1994) N Engl J Med , vol.330 , pp. 1342-1347
    • Poupon, R.E.1    Poupon, R.2    Balkau, B.3
  • 59
    • 0033658752 scopus 로고    scopus 로고
    • The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis
    • C. Corpechot, F. Carrat, A.M. Bonnand, and et al. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis Hepatology 32 2000 1196 1199
    • (2000) Hepatology , vol.32 , pp. 1196-1199
    • Corpechot, C.1    Carrat, F.2    Bonnand, A.M.3
  • 60
    • 84862813779 scopus 로고    scopus 로고
    • Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - A randomized open-label controlled study
    • M.Y. Kim, M.Y. Cho, S.K. Baik, and et al. Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - a randomized open-label controlled study Liver Int 32 2012 977 987
    • (2012) Liver Int , vol.32 , pp. 977-987
    • Kim, M.Y.1    Cho, M.Y.2    Baik, S.K.3
  • 61
    • 33751545838 scopus 로고    scopus 로고
    • A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
    • R. Belfort, S.A. Harrison, K. Brown, and et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis N Engl J Med 355 2006 2297 2307
    • (2006) N Engl J Med , vol.355 , pp. 2297-2307
    • Belfort, R.1    Harrison, S.A.2    Brown, K.3
  • 62
    • 53049101877 scopus 로고    scopus 로고
    • Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
    • G.P. Aithal, J.A. Thomas, P.V. Kaye, and et al. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis Gastroenterology 135 2008 1176 1184
    • (2008) Gastroenterology , vol.135 , pp. 1176-1184
    • Aithal, G.P.1    Thomas, J.A.2    Kaye, P.V.3
  • 63
    • 77951874018 scopus 로고    scopus 로고
    • Pioglitazone, Vitamin E, or placebo for nonalcoholic steatohepatitis
    • A.J. Sanyal, N. Chalasani, K.V. Kowdley, and et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis N Engl J Med 362 2010 1675 1685
    • (2010) N Engl J Med , vol.362 , pp. 1675-1685
    • Sanyal, A.J.1    Chalasani, N.2    Kowdley, K.V.3
  • 64
    • 75449116707 scopus 로고    scopus 로고
    • Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
    • V. Ratziu, F. Charlotte, C. Bernhardt, and et al. Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial Hepatology 51 2010 445 453
    • (2010) Hepatology , vol.51 , pp. 445-453
    • Ratziu, V.1    Charlotte, F.2    Bernhardt, C.3
  • 65
    • 80055028155 scopus 로고    scopus 로고
    • Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
    • C.O. Zein, L.M. Yerian, P. Gogate, and et al. Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial Hepatology 54 2011 1610 1619
    • (2011) Hepatology , vol.54 , pp. 1610-1619
    • Zein, C.O.1    Yerian, L.M.2    Gogate, P.3
  • 66
    • 80055031101 scopus 로고    scopus 로고
    • Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial
    • D.M. Torres, F.J. Jones, J.C. Shaw, and et al. Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trial Hepatology 54 2011 1631 1639
    • (2011) Hepatology , vol.54 , pp. 1631-1639
    • Torres, D.M.1    Jones, F.J.2    Shaw, J.C.3
  • 67
    • 79954764140 scopus 로고    scopus 로고
    • A randomized controlled trial of high-dose ursodeoxycholic acid for nonalcoholic steatohepatitis
    • V. Ratziu, V. de Ledinghen, F. Oberti, and et al. A randomized controlled trial of high-dose ursodeoxycholic acid for nonalcoholic steatohepatitis J Hepatol 54 2011 1011 1019
    • (2011) J Hepatol , vol.54 , pp. 1011-1019
    • Ratziu, V.1    De Ledinghen, V.2    Oberti, F.3
  • 68
    • 84929266699 scopus 로고    scopus 로고
    • Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial
    • S0140-6736(14)61933-4
    • B.A. Neuschwander-Tetri, R. Loomba, A.J. Sanyal, and et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial Lancet 2014 pii: S0140-6736(14)61933-4
    • (2014) Lancet
    • Neuschwander-Tetri, B.A.1    Loomba, R.2    Sanyal, A.J.3
  • 69
    • 84927797734 scopus 로고    scopus 로고
    • Real-time shear-wave elastography: Applicability, reliability and accuracy for clinically significant portal hypertension
    • S0168-8278(14)00925-8
    • B. Procopet, A. Berzigotti, J.G. Abraldes, F. Turon, V. Hernandez-Gea, J.C. García-Pagán, and J. Bosch Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertension J Hepatol 2014 10.1016/j.jhep.2014. 12. 007 pii: S0168-8278(14)00925-8
    • (2014) J Hepatol
    • Procopet, B.1    Berzigotti, A.2    Abraldes, J.G.3    Turon, F.4    Hernandez-Gea, V.5    García-Pagán, J.C.6    Bosch, J.7
  • 70
    • 84898807026 scopus 로고    scopus 로고
    • Role of magnetic resonance elastography in compensated and decompensated liver disease
    • S.K. Asrani, J.A. Talwalkar, P.S. Kamath, V.H. Shah, G. Saracino, L. Jennings, and et al. Role of magnetic resonance elastography in compensated and decompensated liver disease J Hepatol 60 2014 934 939
    • (2014) J Hepatol , vol.60 , pp. 934-939
    • Asrani, S.K.1    Talwalkar, J.A.2    Kamath, P.S.3    Shah, V.H.4    Saracino, G.5    Jennings, L.6
  • 71
    • 79952467377 scopus 로고    scopus 로고
    • The mean values of liver stiffness assessed by Acoustic Radiation Force Impulse elastography in normal subjects
    • A. Popescu, I. Sporea, R. Sirli, S. Bota, M. Focsa, M. Danila, and et al. The mean values of liver stiffness assessed by Acoustic Radiation Force Impulse elastography in normal subjects Med Ultrason 13 2011 33 37
    • (2011) Med Ultrason , vol.13 , pp. 33-37
    • Popescu, A.1    Sporea, I.2    Sirli, R.3    Bota, S.4    Focsa, M.5    Danila, M.6
  • 73
    • 84885951993 scopus 로고    scopus 로고
    • Molecular MRI of collagen to diagnose and stage liver fibrosis
    • B.C. Fuchs, H. Wang, Y. Yang, L. Wei, M. Polasek, D.T. Schuhle, and et al. Molecular MRI of collagen to diagnose and stage liver fibrosis J Hepatol 59 2013 992 998
    • (2013) J Hepatol , vol.59 , pp. 992-998
    • Fuchs, B.C.1    Wang, H.2    Yang, Y.3    Wei, L.4    Polasek, M.5    Schuhle, D.T.6
  • 74
  • 75
    • 84859164941 scopus 로고    scopus 로고
    • Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial
    • G.T. Everson, M.L. Shiffman, J.C. Hoefs, T.R. Morgan, R.K. Sterling, D.A. Wagner, and et al. Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial Hepatology 55 2012 1019 1029
    • (2012) Hepatology , vol.55 , pp. 1019-1029
    • Everson, G.T.1    Shiffman, M.L.2    Hoefs, J.C.3    Morgan, T.R.4    Sterling, R.K.5    Wagner, D.A.6
  • 76
    • 52149083035 scopus 로고    scopus 로고
    • A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT
    • G. Lalazar, O. Pappo, T. Hershcovici, T. Hadjaj, M. Shubi, H. Ohana, and et al. A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT J Viral Hepat 15 2008 716 728
    • (2008) J Viral Hepat , vol.15 , pp. 716-728
    • Lalazar, G.1    Pappo, O.2    Hershcovici, T.3    Hadjaj, T.4    Shubi, M.5    Ohana, H.6
  • 77
    • 84904857264 scopus 로고    scopus 로고
    • Accelerating drug development through collaboration: The hepatitis C drug development advisory group
    • C. Hutchison, A. Kwong, S. Ray, K. Struble, T. Swan, and V. Miller Accelerating drug development through collaboration: the hepatitis C drug development advisory group Clin Pharmacol Ther 96 2014 162 165
    • (2014) Clin Pharmacol Ther , vol.96 , pp. 162-165
    • Hutchison, C.1    Kwong, A.2    Ray, S.3    Struble, K.4    Swan, T.5    Miller, V.6
  • 78
    • 84878930738 scopus 로고    scopus 로고
    • Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
    • Q.M. Anstee, G. Targher, and C.P. Day Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis Nat Rev Gastroenterol Hepatol 10 2013 330 344
    • (2013) Nat Rev Gastroenterol Hepatol , vol.10 , pp. 330-344
    • Anstee, Q.M.1    Targher, G.2    Day, C.P.3
  • 79
    • 34547539830 scopus 로고    scopus 로고
    • Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis
    • C. Ripoll, R. Groszmann, G. Garcia-Tsao, N. Grace, A. Burroughs, R. Planas, and et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis Gastroenterology 133 2007 481 488
    • (2007) Gastroenterology , vol.133 , pp. 481-488
    • Ripoll, C.1    Groszmann, R.2    Garcia-Tsao, G.3    Grace, N.4    Burroughs, A.5    Planas, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.